camptothecin has been researched along with phleomycin d1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bargonetti, J; Gopen, T; Houser, S; Koshlatyi, S; Lu, T | 1 |
Eckert-Boulet, N; Eléouët, M; Gallina, I; Game, J; Germann, SM; Hamou, W; Lisby, M; Mathiasen, DP; Thodberg, S | 1 |
2 other study(ies) available for camptothecin and phleomycin d1
Article | Year |
---|---|
Camptothecin and Zeocin can increase p53 levels during all cell cycle stages.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bleomycin; Camptothecin; Cell Cycle; DNA Damage; DNA, Neoplasm; Drug Stability; Humans; Leukemia, Myeloid; Phosphorylation; Serine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Physical mapping and cloning of RAD56.
Topics: Acetylation; Bleomycin; Camptothecin; Chromosome Mapping; Cloning, Molecular; DNA Damage; DNA Repair; DNA, Fungal; Hydroxyurea; Methyl Methanesulfonate; Mutation; N-Terminal Acetyltransferase B; Phenotype; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; X-Rays | 2013 |